Works matching DE "PROTEIN-tyrosine kinases"
Results: 5000
Design and Synthesis of a <sup>18</sup>F‐Radiolabeled Pyrrolo[2,3‐d]pyrimidine Ligand as a CSF1R Receptor PET Imaging Agent.
- Published in:
- Journal of Labelled Compounds & Radiopharmaceuticals, 2025, v. 68, n. 1/2, p. 1, doi. 10.1002/jlcr.4131
- By:
- Publication type:
- Article
KIRA6 is an Effective and Versatile Mast Cell Inhibitor of IgE‐mediated Activation.
- Published in:
- European Journal of Immunology, 2025, v. 55, n. 2, p. 1, doi. 10.1002/eji.202451348
- By:
- Publication type:
- Article
Ripretinib for the treatment of advanced, imatinib‐resistant gastrointestinal stromal tumors.
- Published in:
- Journal of Digestive Diseases, 2024, v. 25, n. 9/10, p. 559, doi. 10.1111/1751-2980.13229
- By:
- Publication type:
- Article
Downregulation of AATK enhances susceptibility to ferroptosis by promoting endosome recycling in gefitinib‐resistant lung cancer cells.
- Published in:
- Journal of Pathology, 2025, v. 265, n. 4, p. 422, doi. 10.1002/path.6393
- By:
- Publication type:
- Article
Comprehensive Analysis of TEK Variants in Patients With Vascular Malformations.
- Published in:
- Clinical Genetics, 2025, v. 107, n. 4, p. 458, doi. 10.1111/cge.14667
- By:
- Publication type:
- Article
JAK2 is a critical therapeutic target in VEXAS syndrome treated with ruxolitinib.
- Published in:
- British Journal of Haematology, 2025, v. 206, n. 2, p. 758, doi. 10.1111/bjh.19979
- By:
- Publication type:
- Article
Pre-existing cardiovascular disease is associated with an increased risk of cardiovascular events during Bruton tyrosine kinase inhibitor therapy.
- Published in:
- Oncologist, 2025, v. 30, n. 2, p. 1, doi. 10.1093/oncolo/oyae229
- By:
- Publication type:
- Article
MDM2 inhibitors induce apoptosis by suppressing MDM2 and enhancing p53, Bax, Puma and Noxa expression levels in imatinib‑resistant chronic myeloid leukemia cells.
- Published in:
- Biomedical Reports, 2025, v. 22, n. 4, p. N.PAG, doi. 10.3892/br.2025.1943
- By:
- Publication type:
- Article
Targeted therapy in pediatric central nervous system tumors: a review from the National Pediatric Cancer Foundation.
- Published in:
- Frontiers in Oncology, 2025, p. 1, doi. 10.3389/fonc.2025.1504803
- By:
- Publication type:
- Article
Exploring the Efficacy, Safety, and Clinical Implications of Deucravacitinib in East Asians with Psoriasis: A Narrative Review.
- Published in:
- Journal of Clinical Medicine, 2025, v. 14, n. 5, p. 1746, doi. 10.3390/jcm14051746
- By:
- Publication type:
- Article
Design, Synthesis, and Cytotoxicity Evaluation of Novel Indolin-2-One Based Molecules on Hepatocellular Carcinoma HepG2 Cells as Protein Kinase Inhibitors.
- Published in:
- Molecules, 2025, v. 30, n. 5, p. 1105, doi. 10.3390/molecules30051105
- By:
- Publication type:
- Article
LC-MS/MS combined with network pharmacology and molecular docking to explore the targets and mechanisms of antioxidant effects of strawberry leaves.
- Published in:
- China Surfactant Detergent & Cosmetics (2097-2806), 2025, v. 55, n. 1, p. 63, doi. 10.3969/j.issn.2097-2806.2025.01.008
- By:
- Publication type:
- Article
Cholesterol inhibits assembly and oncogenic activation of the EphA2 receptor.
- Published in:
- Communications Biology, 2025, v. 8, n. 1, p. 1, doi. 10.1038/s42003-025-07786-6
- By:
- Publication type:
- Article
From the Masterclasses in Dermatology 2024 Meeting: Updates in Psoriasis Treatments.
- Published in:
- Journal of Clinical & Aesthetic Dermatology, 2025, v. 18, n. 2, p. 16
- By:
- Publication type:
- Article
Review of Janus Kinase Inhibitors as Therapies for Noninfectious Uveitis.
- Published in:
- Journal of Ocular Pharmacology & Therapeutics, 2025, v. 41, n. 2, p. 44, doi. 10.1089/jop.2024.0100
- By:
- Publication type:
- Article
Discoid Domain Receptors Signaling in Macrophages-Mediated Diseases.
- Published in:
- International Journal of General Medicine, 2025, v. 18, p. 907, doi. 10.2147/IJGM.S487093
- By:
- Publication type:
- Article
Multimodal Adaptations to Expiratory Musculature-Targeted Resistance Training: A Preliminary Study in Healthy Young Adults.
- Published in:
- Journal of Speech, Language & Hearing Research, 2025, v. 68, n. 3, p. 987, doi. 10.1044/2024_JSLHR-24-00294
- By:
- Publication type:
- Article
Jiangzhi Granule Ameliorates JNK-Mediated Mitochondrial Dysfunction to Reduce Lipotoxic Liver Injury in NASH.
- Published in:
- Diabetes, Metabolic Syndrome & Obesity: Targets & Therapy, 2025, v. 18, p. 23, doi. 10.2147/DMSO.S492174
- By:
- Publication type:
- Article
Receptor tyrosine kinase-like orphan receptor serves as a potential target in cancer immunotherapy.
- Published in:
- Journal of Leukocyte Biology, 2025, v. 117, n. 2, p. 1, doi. 10.1093/jleuko/qiae141
- By:
- Publication type:
- Article
Case report: A patient with EGFR L861Q positive adenosquamous lung carcinoma transforming into large cell neuroendocrine cancer after treatment with Almonertinib.
- Published in:
- Frontiers in Oncology, 2025, p. 1, doi. 10.3389/fonc.2025.1453066
- By:
- Publication type:
- Article
Functional Remediation Improves Serum BDNF and TrkB Levels in Euthymic Patients with Bipolar Disorder: A Randomized Trial Study.
- Published in:
- Neuropsychiatric Disease & Treatment, 2025, v. 21, p. 115, doi. 10.2147/NDT.S502176
- By:
- Publication type:
- Article
Investigating Computational Insights Into Plantderived Terpenoids of Bangladesh: Prospects for Anti-rheumatoid Arthritis Medication.
- Published in:
- Pharmaceutical & Biomedical Research, 2024, v. 10, n. 4, p. 331, doi. 10.32598/PBR.10.4.1294.1
- By:
- Publication type:
- Article
Synthesis, Characterization, and In Vitro Anticancer Studies of New 1,8-Naphthyridine Substituted Schiff Base Derivatives and Their Molecular Docking.
- Published in:
- Russian Journal of General Chemistry, 2025, v. 95, n. 1, p. 209, doi. 10.1134/S1070363224609062
- By:
- Publication type:
- Article
Design, Synthesis, In Vitro Anticancer and ADMET Studies of Piperazine-Pyrazolo-Quinoxalin-2(1H)-one Conjugate as EGFR Targeting Agents.
- Published in:
- Russian Journal of General Chemistry, 2025, v. 95, n. 1, p. 184, doi. 10.1134/S1070363224610366
- By:
- Publication type:
- Article
The Role of Clinicopathological Features in Tyrosine Kinase Inhibitory Duration in EGFR Mutant Metastatic Non-Small Cell Lung Cancer.
- Published in:
- Journal of Clinical Medicine, 2025, v. 14, n. 4, p. 1149, doi. 10.3390/jcm14041149
- By:
- Publication type:
- Article
Correction: Zhao et al. Fasciola gigantica Recombinant Abelson Tyrosine Protein Kinase (r Fg Abl) Regulates Various Functions of Buffalo Peripheral Blood Mononuclear Cells. Animals 2025, 15 , 179.
- Published in:
- 2025
- By:
- Publication type:
- Correction Notice
Whole exome sequencing analysis of a patient with myeloid/lymphoid neoplasms with eosinophilia and tyrosine kinase gene fusions with ETV6::LYN fusion gene.
- Published in:
- Annals of Hematology, 2025, v. 104, n. 1, p. 809, doi. 10.1007/s00277-024-06135-7
- By:
- Publication type:
- Article
Relative Quantitation of EFNA1 Expression in Mouse Heart Tissue Histologic Sections Using MALDI-MSI.
- Published in:
- International Journal of Molecular Sciences, 2025, v. 26, n. 4, p. 1398, doi. 10.3390/ijms26041398
- By:
- Publication type:
- Article
NTRK rearranged spindle cell neoplasm of the uterine cervix: a rare case report and literature review.
- Published in:
- BMC Women's Health, 2025, v. 25, n. 1, p. 1, doi. 10.1186/s12905-025-03574-w
- By:
- Publication type:
- Article
Mapping kinase domain resistance mechanisms for the MET receptor tyrosine kinase via deep mutational scanning.
- Published in:
- eLife, 2025, p. 1, doi. 10.7554/eLife.101882
- By:
- Publication type:
- Article
Roles of EphA2 Receptor in Angiogenesis Signaling Pathway of Glioblastoma Multiforme.
- Published in:
- Malaysian Journal of Medical Sciences, 2018, v. 25, n. 6, p. 22, doi. 10.21315/mjms2018.25.6.3
- By:
- Publication type:
- Article
LOW INCIDENCE OF FLT3 GENE MUTATION IN MALAY PATIENTS WITH ACUTE MYELOID LEUKEMIA.
- Published in:
- Malaysian Journal of Medical Sciences, 2008, p. 129
- By:
- Publication type:
- Article
FLT3 GENE INTERNAL TANDEM DUPLICATION IN ADULT ACUTE MYELOID LEUKEMIA PATIENTS.
- Published in:
- Malaysian Journal of Medical Sciences, 2007, v. 14, p. 43
- By:
- Publication type:
- Article
C-KIT EXPRESSION IN SYNOVIAL SARCOMAS.
- Published in:
- Malaysian Journal of Medical Sciences, 2006, v. 13, p. 186
- By:
- Publication type:
- Article
Low Stability and a Conserved N-Glycosylation Site Are Associated with Regulation of the Discoidin Domain Receptor Family by Glucose via Post-Translational N-Glycosylation.
- Published in:
- Bioscience, Biotechnology & Biochemistry, 2013, v. 77, n. 9, p. 1907, doi. 10.1271/bbb.130351
- By:
- Publication type:
- Article
A Silent Mutation Made Possible Efficient Production of Active Human Frk Tyrosine Kinase in Escherichia coli.
- Published in:
- Bioscience, Biotechnology & Biochemistry, 2010, v. 74, n. 1, p. 125, doi. 10.1271/bbb.90648
- By:
- Publication type:
- Article
The Inhibitory Mechanisms of the Tyrosine Kinase Inhibitors Herbimycin A, Genistein, and Tyrphostin B48 with Regard to the Function of the Aryl Hydrocarbon Receptor in Caco-2 Cells.
- Published in:
- Bioscience, Biotechnology & Biochemistry, 2010, v. 74, n. 1, p. 36, doi. 10.1271/bbb.90438
- By:
- Publication type:
- Article
Renal Cancer.
- Published in:
- Current Medical Literature: Urology, 2011, v. 17, n. 2, p. 51
- By:
- Publication type:
- Article
Expression frequency of c‐kit isoforms and its prognostic potential in canine mammary tumours.
- Published in:
- Veterinary & Comparative Oncology, 2020, v. 18, n. 3, p. 303, doi. 10.1111/vco.12549
- By:
- Publication type:
- Article
Investigation of thyroid function in dogs treated with the tyrosine kinase inhibitor toceranib.
- Published in:
- Veterinary & Comparative Oncology, 2020, v. 18, n. 3, p. 433, doi. 10.1111/vco.12538
- By:
- Publication type:
- Article
Phosphorylated KIT as a predictor of outcome in canine mast cell tumours treated with toceranib phosphate or vinblastine.
- Published in:
- Veterinary & Comparative Oncology, 2020, v. 18, n. 2, p. 169, doi. 10.1111/vco.12525
- By:
- Publication type:
- Article
In vitro and in vivo effects of toceranib phosphate on canine osteosarcoma cell lines and xenograft orthotopic models.
- Published in:
- Veterinary & Comparative Oncology, 2020, v. 18, n. 1, p. 117, doi. 10.1111/vco.12562
- By:
- Publication type:
- Article
Effects of ibrutinib on proliferation and histamine release in canine neoplastic mast cells.
- Published in:
- Veterinary & Comparative Oncology, 2019, v. 17, n. 4, p. 553, doi. 10.1111/vco.12520
- By:
- Publication type:
- Article
Expression of receptor tyrosine kinase targets PDGFR-β, VEGFR2 and KIT in canine transitional cell carcinoma.
- Published in:
- Veterinary & Comparative Oncology, 2018, v. 16, n. 1, p. E117, doi. 10.1111/vco.12344
- By:
- Publication type:
- Article
Association of prognostic features and treatment on survival time of dogs with systemic mastocytosis: A retrospective analysis of 40 dogs.
- Published in:
- Veterinary & Comparative Oncology, 2018, v. 16, n. 1, p. E194, doi. 10.1111/vco.12373
- By:
- Publication type:
- Article
Prospective evaluation of toceranib phosphate in metastatic canine osteosarcoma.
- Published in:
- Veterinary & Comparative Oncology, 2018, v. 16, n. 1, p. E23, doi. 10.1111/vco.12328
- By:
- Publication type:
- Article
The tyrosine kinase inhibitor toceranib in feline injection site sarcoma: efficacy and side effects.
- Published in:
- Veterinary & Comparative Oncology, 2017, v. 15, n. 2, p. 632, doi. 10.1111/vco.12207
- By:
- Publication type:
- Article
Assessment of predictive molecular variables in feline oral squamous cell carcinoma treated with stereotactic radiation therapy.
- Published in:
- Veterinary & Comparative Oncology, 2016, v. 14, n. 1, p. 39, doi. 10.1111/vco.12050
- By:
- Publication type:
- Article
Met interacts with EGFR and Ron in canine osteosarcoma.
- Published in:
- Veterinary & Comparative Oncology, 2013, v. 11, n. 2, p. 124, doi. 10.1111/j.1476-5829.2011.00309.x
- By:
- Publication type:
- Article
Safety evaluation of combination toceranib phosphate (Palladia®) and piroxicam in tumour-bearing dogs (excluding mast cell tumours): a phase I dose-finding study Safety evaluation of combination toceranib phosphate (Palladia®) and piroxicam in tumour-bearing dogs (excluding mast cell tumours): a phase I dose-finding study
- Published in:
- Veterinary & Comparative Oncology, 2012, v. 10, n. 3, p. 184, doi. 10.1111/j.1476-5829.2011.00265.x
- By:
- Publication type:
- Article